Metal-on-metal hip implants, like the DePuy Hip Recall and DePuy
Pinnacle hip, have been linked to metal poisoning or metallosis, which could
cause serious problems with the hip replacement. Symptoms often involve
the development of pain, inflammation and difficulty walking as the
metal-on-metal parts rub against each other and release debris or small metal
fragments.Metallosis, or metallic
poisoning, has been shown to cause the breakdownof bone marrow and white
blood cells. A 2009 study in the United Kingdom of 660 DePuy Hip
complications patients went further, linking metallic poisoning to problems
such as vision loss, soft tissue and muscle damage, hearing loss and hip
pain.
Metallosis is characteristic of
metal-on-metal or metal-on-polyethylene implants. It can lead to aseptic
fibrosis, local necrosis or even help to cause metallic corrosion and increase
the chances of DePuy
hip failure.Approximately 1,000 patients have reported problems with their
DePuy Hip Implants since 2005. From only 2007 to 2009,
the FDA received over 600 adverse event reports from doctors who were evaluating patients returning with problems so severe that they required surgery to remove their implants.Experts have indicated that at least 13% of the 93,000 DePuy Hip patients who received the implant will need to undergo surgery to remove it. Specialized blood tests can be used to detect levels of toxic metal in DePuy hip implant patients. In some cases, patients have been found with 100 times the normal level of chromium and cobalt in the body.
the FDA received over 600 adverse event reports from doctors who were evaluating patients returning with problems so severe that they required surgery to remove their implants.Experts have indicated that at least 13% of the 93,000 DePuy Hip patients who received the implant will need to undergo surgery to remove it. Specialized blood tests can be used to detect levels of toxic metal in DePuy hip implant patients. In some cases, patients have been found with 100 times the normal level of chromium and cobalt in the body.
As part of the DePuy Hip Recall issued on
August 26, 2010, the company has indicated it will pay “reasonable and
customary costs of monitoring and treatment” related to the recalled hip
implants. This may include the cost of revision surgery; however, it does
not compensate patients for pain and suffering, lost time or wages, or the risk
of undergoing a repeat surgery.In September 2011, data from the National
Joint Registry for England and Wales indicated that the seven year failure
rate for metal-on-metal hip replacements was 14%, compared with a failure rate
of only 4.7% for all artificial hip implants. The DePuy ASR metal-on-metal
hip has been a particular problem, with a six year failure rate of nearly 30%.
No comments:
Post a Comment